Revvity Announces Financial Results for the Second Quarter of 2026
Revvity reported Q2 2026 revenue of $730 million with pro forma adjusted EPS of $1.41, driven by a 12% pro forma increase in Diagnostics revenue. The company raised its full-year 2026 guidance, forecasting revenue of $2.83-$2.86 billion and pro forma adjusted EPS of $5.30-$5.40, citing increased demand and momentum in end markets.
Key figures
- Eps
- 1.41
- Revenue
- $730 million
- Guidance
- FY26 revenue $2.83-$2.86 billion, pro forma adjusted EPS $5.30-$5.40
- Revenue Yoy
- 4%
- Gaap eps
- 0.48
- Pro forma revenue
- $711 million
- Pro forma organic growth
- 3%
- Adjusted operating margin
- 28.9%
- Reported operating margin
- 12.2%
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.